Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Rab11 family-interacting protein 5 (RAB11FIP5) is a cytosolic adaptor protein involved in regulating protein trafficking from apical recycling endosomes to the plasma membrane[1][2][9]. It binds to small GTPases of the Rab family—particularly RAB11A and RAB25—and helps coordinate slow recycling of membrane proteins, such as endocytosed receptors, by tethering vesicles to cytoskeletal motors like kinesin II[2]. RAB11FIP5 plays important roles in exocytosis, such as insulin granule release, and in specialized processes like maintaining neuronal AMPA receptor localization and cell polarity, as well as facilitating cellular responses to acidic environments via regulation of V-ATPase[2][9]. It is associated with neurodevelopmental and autoimmune pathologies, but is not considered a direct therapeutic target, nor are there approved drugs interacting with it[1][6][8].
Not applicable; no direct drugs targeting this protein reported
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Rab11 family-interacting protein 5 (RAB11FIP5).